IP Library Granted Patent US 12,436,657
Granted Patent B1
US 12,436,657 · App. 19/186,298 · Granted Oct 7, 2025

System and method for generating a visual representation of an execution sequence within a graphical user interface

Inventors: Blake Browder (Dallas, TX); Joy Figarsky (Little Rock, AR)
Assignee: Signet Health Corporation
G06F3/0481G16H10/60G06F3/0486
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,436,657
App. No.
19/186,298
Granted
Oct 7, 2025
Kind
B1
Abstract

A system for generating a visual representation of an execution sequence within a graphical user interface, including: at least a computing device, wherein the computing device comprises: a memory; a display device; and at least a processor configured to generate a display data structure including: providing a plurality of visual elements associated with execution sequence data and action sequence data and at least an event handler; linking a first visual element to the execution sequence data, linking a second visual element to the action sequence data; verifying the action sequence data; adjust the execution sequence data as a function of the verified action sequence data; classify the adjusted execution sequence data to a status; linking a third visual element to the status; generate the display data structure; and configure, using the display data structure, the display device to display the data structure.

Claims (27)

1. A system for generating a visual representation of an execution sequence within a graphical user interface, wherein the system comprises:

at least a computing device, wherein the computing device comprises: a memory; and

at least a processor communicatively connected to the memory, wherein the memory contains instructions configuring the at least a processor to: generate a display data structure, wherein generating the display data structure further comprises linking at least a visual element to at least a part of a set of sequence data, wherein linking comprises:

tokenizing a natural language input received for the at least a visual element into a plurality of components using a natural language processing model;

identifying semantic data from the plurality of components using the natural language processing model; and

linking the at least a visual element to at least a part of the set of sequence data as a function of the semantic data using the natural language processing model;

update the display data structure using the at least a visual element and at least an event handler; and

configure, using the display data structure, a display device to display the display data structure within a graphical user interface, wherein linking the at least a visual element comprises: determining a status of the at least a part of the set of sequence data as a function of a patient's adherence.

2. The system of claim 1 , wherein the at least a visual element comprises at least a chatbot feature.

3. The system of claim 1 , wherein linking the at least a visual element further comprises: linking the at least a visual element to the at least a part of the set of sequence data as a function of the status.

4. The system of claim 3 , wherein the at least a visual element comprises an interactive element that displays a timeline of the set of sequence data and the status of each.

5. The system of claim 1 , wherein generating the display data structure further comprises verifying at least a part of the set of sequence data using a verification module by identifying discrepancies in at least a part of the set of sequence data as a function of a cluster execution sequence data.

6. The system of claim 5 , wherein generating the display data structure further comprises generating a notification through the at least a visual element as a function of the identified discrepancies.

7. The system of claim 5 , wherein generating the display data structure further comprises: training a verification machine-learning model using verification training data, wherein the verification training data comprises exemplary verified sequence data; and identifying the discrepancies in at least a part of the set of sequence data using the trained verification machine-learning model.

8. The system of claim 1 , wherein linking the at least a visual element to the set of sequence data comprises: generating a comparison value between the set of sequence data; and modifying a visual parameter of the at least a visual element as a function of the comparison value.

9. The system of claim 1 , wherein displaying the display data structure within the graphical user interface comprises: calculating a predicted execution sequence completion time for at least a part of the set of sequence data; and displaying, using the graphical user interface, the predicted execution sequence completion time.

10. The system of claim 9 , wherein calculating the predicted execution sequence completion time comprises: training a score machine-learning model using score training data, wherein the score training data comprises historical sequence data correlated to exemplary priority scores; and assigning a priority ranking to the predicted execution sequence completion time as a function of an adherence level using the trained score machine-learning model.

11. A method for generating a visual representation of an execution sequence within a graphical user interface, wherein the method comprises: generating, using at least a processor, a display data structure, wherein generating the display data structure further comprises linking at least a visual element to at least a part of a set of sequence data, wherein linking comprises: tokenizing a natural language input received for the at least a visual element into a plurality of components using a natural language processing model; identifying semantic data from the plurality of components using the natural language processing model; and linking the at least a visual element to at least a part of the set of sequence data as a function of the semantic data using the natural language processing model; updating, using the at least a processor, the display data structure using the at least a visual element and at least an event handler; and configuring, using the at least a processor and the display data structure, a display device to display the display data structure within a graphical user interface, wherein linking the at least a visual element comprises: determining a status of the at least a part of the set of sequence data as a function of a patient's adherence.

12. The method of claim 11 , wherein the at least a visual element comprises at least a chatbot feature.

13. The method of claim 11 , wherein linking the at least a visual element further comprises: linking the at least a visual element to the at least a part of the set of sequence data as a function of the status.

14. The method of claim 13 , wherein the at least a visual element comprises an interactive element that displays a timeline of the set of sequence data and the status of each.

15. The method of claim 11 , wherein generating the display data structure further comprises verifying at least a part of the set of sequence data using a verification module by identifying discrepancies in at least a part of the set of sequence data as a function of a cluster execution sequence data.

16. The method of claim 15 , wherein generating the display data structure further comprises generating a notification through the at least a visual element as a function of the identified discrepancies.

17. The method of claim 15 , wherein generating the display data structure further comprises: training a verification machine-learning model using verification training data, wherein the verification training data comprises exemplary verified sequence data; and identifying the discrepancies in at least a part of the set of sequence data using the trained verification machine-learning model.

18. The method of claim 11 , wherein linking the at least a visual element to the set of sequence data comprises: generating a comparison value between the set of sequence data; and modifying a visual parameter of the at least a visual element as a function of the comparison value.

19. The method of claim 11 , wherein displaying the display data structure within the graphical user interface comprises: calculating a predicted execution sequence completion time for at least a part of the set of sequence data; and displaying, using the graphical user interface, the predicted execution sequence completion time.

20. The method of claim 19 , wherein calculating the predicted execution sequence completion time comprises: training a score machine-learning model using score training data, wherein the score training data comprises historical sequence data correlated to exemplary priority scores; and assigning a priority ranking to the predicted execution sequence completion time as a function of an adherence level using the trained score machine-learning model.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 72292 FRAME 767. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 16, 2025
From: SIGNET HEALTH CORPORATION
To: BH OPERATIONS, LLC
Reel/Frame 073992/0817 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2025
From: SIGNET HEALTH CORPORATION
To: BEHAVIORAL HEALTH OPERATIONS, LLC
Reel/Frame 072292/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2025
From: BROWDER, BLAKE; FIGARSKY, JOY
To: SIGNET HEALTH CORPORATION
Reel/Frame 070914/0601 →
Continuity (1)
Continuation 18957784 · Nov 24, 2024
References Cited (38)
US 10381108B2 · Zhou · 2019 [cited by examiner]
US 10902341B1 · Qureshi · 2021 [cited by examiner]
US 11308432B2 · Covell · 2022 [cited by examiner]
US 11382720B2 · Kopelman · 2022 [cited by examiner]
US 11976265B2 · Gonzalez · 2024 [cited by examiner]
US 12080286B2 · Nouri · 2024 [cited by examiner]
US 12182388B1 · Pomatto · 2024 [cited by examiner]
US 20030050801A1 · Ries · 2003 [cited by examiner]
US 20040111293A1 · Firanek · 2004 [cited by examiner]
US 20070168225A1 · Haider · 2007 [cited by examiner]
US 20070226005A1 · Smith · 2007 [cited by examiner]
US 20080305454A1 · Kitching · 2008 [cited by examiner]
US 20080306724A1 · Kitching · 2008 [cited by examiner]
US 20100124731A1 · Groscurth · 2010 [cited by examiner]
US 20120323827A1 · Lakshmanan · 2012 [cited by examiner]
US 20130289963A1 · Betrouni · 2013 [cited by examiner]
US 20150058043A1 · Heinemann · 2015 [cited by examiner]
US 20160210424A1 · Di Battista · 2016 [cited by examiner]
US 20170286626A1 · Jayakumar · 2017 [cited by examiner]
US 20180158539A1 · Gupta · 2018 [cited by examiner]
US 20180277244A1 · Gupta · 2018 [cited by examiner]
US 20180342313A1 · Gupta · 2018 [cited by examiner]
US 20200118302A1 · Schlake · 2020 [cited by examiner]
US 20200164231A1 · Cannata · 2020 [cited by examiner]
US 20200387550A1 · Cappetta · 2020 [cited by examiner]
US 20210142000A1 · Vis · 2021 [cited by examiner]
US 20210158941A1 · Taylor · 2021 [cited by examiner]
US 20210165829A1 · Dornbush · 2021 [cited by examiner]
US 20210201240A1 · Yanamala · 2021 [cited by examiner]
US 20210303578A1 · Dua · 2021 [cited by examiner]
US 20210303636A1 · Dua · 2021 [cited by examiner]
US 20220398547A1 · Wang · 2022 [cited by examiner]
US 20220406427A1 · Bayuzick · 2022 [cited by examiner]
US 20230244989A1 · Riva · 2023 [cited by examiner]
US 20230351351A1 · Nguyen · 2023 [cited by examiner]
US 20240008957A1 · Mednikov · 2024 [cited by examiner]
US 20250021461A1 · Sharpe · 2025 [cited by examiner]
US 20250021658A1 · Sharpe · 2025 [cited by examiner]